Articles Archives - Page 101 of 750

TuesdayJul 30, 2024 9:00 am

SuperCom Ltd. (NASDAQ: SPCB) EM Technology Highly Competitive in Expanding Field of Court-administered Offender Monitoring

Cost-effective and recidivism-reducing alternatives to incarceration continue to occupy a priority for criminal justice systems worldwide as societies grapple with balancing concerns ranging from minimizing threats to sustaining positive work and family environments During the past four decades, electronic monitoring has emerged as a way to help individuals continue functioning positively within their communities after they have been convicted of criminal behavior Israel-based SuperCom Ltd. is positioning itself to be competitive in a field of related government-ordered service contracts, developing a suite of secure identification and digital monitoring products as an end-to-end solution for electronic monitoring programs The company is…

MondayJul 29, 2024 1:00 pm

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Enters Definitive Agreement to Embark on New Journey Together with Koito

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high performance lidar solutions, is announcing the signing of a definitive agreement. The agreement provides for the acquisition of Cepton by Koito Manufacturing Co. Ltd. (TSE: 7276), a leading automotive tier one supplier. Specifically, Koito will acquire all the outstanding capital stock of Cepton not owned by itself in an all-cash transaction, with Cepton stockholders receiving $3.17 per share in cash. According to the announcement, the proposed transaction has been approved by each company’s Board of Directors and recommended to Cepton’s stockholders by Cepton’s Board of Directors. It is expected…

MondayJul 29, 2024 9:45 am

2025 Life Sciences Conference Calendar Announced: Premier Conferences for Industry Professionals

The life sciences sector is set to experience a year of innovation, collaboration, and breakthrough discoveries with the announcement of DGE’s 2025 Life Sciences Conference Calendar. Industry professionals, researchers and key stakeholders will have the opportunity to attend a series of events designed to foster knowledge exchange, showcase cutting-edge research, and facilitate networking among peers. View the full calendar now. 5th Risk-Based Quality Management Summit: The 5th RBQM Summit in Philadelphia, PA will bring together RBQM, clinical operations, and risk management colleagues to discuss the latest risk planning strategies. Attendees can expect interactive panel discussions and unparalleled networking opportunities. Chief…

MondayJul 29, 2024 9:00 am

ECGI Holdings Inc. (ECGI) Strategically Aligning Operations to Harness Opportunities in Burgeoning Global Equestrian and Luxury Markets

ECGI Holdings is making strategic moves to capitalize on the projected growth in various markets, including the global equestrian apparel market, equestrian equipment and tack market, and the greater overall equestrian market The company recently announced the planned launch of a new line of equestrian apparel under Pacific Saddlery’s Allon brand This new collection is intended to elevate the standard of equestrian apparel and will feature innovative designs that embody luxury, quality, and an unmatched level of craftsmanship ECGI holds that its targeted markets present huge opportunities for generating consistent revenue and supporting continued growth, its status as a relatively…

FridayJul 26, 2024 9:00 am

Clene Inc. (NASDAQ: CLNN) Discusses Important Developments of CNM-Au8(R) and Its Novel Technology During Xtalks Podcast

Clene's mission is to transform the treatment of neurodegenerative diseases with a new class of drugs, potentially impacting the lives of millions The company’s uniquely structured gold nanocrystals have the remarkable ability to convert critical energetic metabolites in living cells for the production of ATP, the essential energy currency for cellular functions, offering disease combatting capabilities Clene is currently preparing for Phase 3 clinical trials of CNM-Au8for ALS and MS, following successful early studies Xtalks Life Science Podcast recently featured Karen S. Ho, PhD, Vice President of Translational Medicine for Clene (NASDAQ: CLNN), a late-stage biopharmaceutical company focused on protecting…

ThursdayJul 25, 2024 9:45 am

Nightfood Holdings Inc. (NGTF) Eyes Growth with CarryOut Acquisition

Nightfood made its name in the sleep-friendly snack market, but has made two acquisitions diversifying operations recently to capitalize on an emerging market and a reemerging company Nightfood signed an LOI to acquire SWC Group, d/b/a Carryoutsupplies.com Carryoutsupplies.com has serviced over 7,000 wholesale accounts since inception in 2004, but faced extreme challenges in the face of the global covid pandemic Business is returning, presenting an opportunity for Nightfood to grow sales that reached $2 million in 2023 Nightfood Holdings (OTCQB: NGTF) is at it again. The Tarrytown, NY-based company built its name with sleep-friendly snacks and is now starting to…

ThursdayJul 25, 2024 9:00 am

PaxMedica Inc. (NASDAQ: PXMD) Developing Treatments for Underserved Neurological Disorders

PaxMedica is preparing to submit a New Drug Application to the U.S. Food and Drug Administration for suramin to treat Human African Trypanosomiasis On June 27th, PaxMedica will have a Type C meeting with the FDA, pivotal for the progress of PAX-101, their leading drug candidate for autism treatment, within the regulatory framework The outcomes of this FDA meeting are crucial, representing a key moment for PaxMedica to demonstrate the therapeutic potential and public health benefits of PAX-101 The global ASD therapeutics market is projected to grow from $2.01 billion in 2023 to $3.42 billion by 2030, driven by increasing…

WednesdayJul 24, 2024 9:45 am

SenesTech Inc.’s (NASDAQ: SNES) Evolve(TM) – Offering Sustainable and Humane Solution to NYC’s Rat Problem

New York City has received lots of backlash, mainly from People for the Ethical Treatment of Animals (“PETA”), for its approach to addressing its rat problem Its approach, so far, has been characterized by the use of traps, poisons, and its “Trash Revolution” program, all of which have been unsustainable SenesTech, a rodent fertility control product provider, through its flagship Evolve(TM) product, offers an alternative that could potentially eliminate the entire rodent population in 12 to 18 months This solution avoids the adverse effects of the use of poisons, both to humans and other animals, and offers a sustainable, more…

WednesdayJul 24, 2024 9:00 am

InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related Macular Degeneration

Age-related macular degeneration is a disease significantly impacting the quality of life, making it difficult for individuals to perform everyday activities such as reading, driving, and recognizing faces InMed is currently developing a pipeline of drugs, like INM-089, to treat diseases with a high unmet medical need Delivers improved retinal pigment epithelium integrity, neuroprotection and photoreceptor improvement in in vivo preclinical disease model Age-related macular degeneration (“AMD”) is a prevalent eye condition that primarily affects older adults, leading to vision loss in the central part of the retina, known as the macula. This disease significantly impacts the quality of life, making it…

TuesdayJul 23, 2024 9:45 am

Annovis Bio Inc. (NYSE: ANVS) Announces New Executive Team Members

The new executive team includes Mark White, Alexander Morin, Hilda Maibach, and Blake Jensen These additions are pivotal as the company makes strides toward bringing flagship drug candidate buntanetap closer to New Drug Application (“NDA”) status and to market Annovis Bio (NYSE: ANVS), a pioneering late-stage clinical drug platform company focusing on transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”), is thrilled to welcome four seasoned professionals to its executive team. Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis Bio, said the company was delighted to have this strong group of individuals join…

Site Search

Company Search

Category: Articles